Site Setup

The purpose of the Site Setup stop to ensure that a clinical research site is ready to conduct a clinical trial.

DTRA_Tubestop Icons-02

Description

Clinical trial site setup involves a number of tasks, including:

  • Providing training: Clinical research staff must be trained on the protocol and all procedures for the clinical trial.
  • Providing supplies: Clinical research sites must be equipped with the necessary supplies to conduct the clinical trial.
  • Establishing a quality assurance program: Clinical research sites must establish a quality assurance program to ensure that the clinical trial is conducted in a compliant and ethical manner.

DCT-specific Considerations/Inputs

DCTs may be conducted at a combination of traditional and alternative site locations. The nature and extent of training required will depend on trial specific processes and assessments, and who will be conducting them. Recommend documenting workflows for key processes identifying roles and responsibilities for site staff and local providers.

This includes training on any new study management and or data collection platforms, patient engagement tools, remote monitoring or wearable devices used to collect data.  


Tools

Alternative Sites coLab outputs for training and PI oversight needs

DCT Regulatory Documentation Recommendations (1572 coLab Deliverables)

Bring Your Own Technology (BYOT)


Regulatory Documents

FDA/U.S.

21 CFR Part 312 Investigational New Drug Application

View

Health Information Portability and Accountability Act (HIPAA)

View

U.S. FDA Final Guidance Document: Conducting Clinical Trials With Decentralized Elements Guidance for Industry, Investigators, and Other Interested Parties - September 2024

View

U.S. FDA Draft Guidance Document: Digital Health Technologies for Remote Data Acquisition in Clinical Investigations

View

Europe/EMA

European Medicines Agency Recommendation Paper on Decentralised Element in Clinical Trials Version 01, 13 December 2022

View

The Principles of ICH GCP, Integrated Addendum to ICH R6(R1): Guideline for Good Clinical Practice ICH E6(R2) Section 2.7 ,2.8

View

INVESTIGATOR: ICH E6 (R2) Good clinical practice (Sections 4.15, 4.2.5, 4.2.6)

View

General Data Protection Regulation

View

Reference Documents

JMIR - Investigator Experiences Using Mobile Technologies in Clinical Research: Qualitative Descriptive Study

View